UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034393
Receipt number R000039211
Scientific Title Effect of continual intake of Satsuma mandarin on skin carotenoid level in human.
Date of disclosure of the study information 2018/11/01
Last modified on 2021/04/07 09:35:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of continual intake of Satsuma mandarin on skin carotenoid level in human.

Acronym

Effect of Satsuma mandarin on skin carotenoid level.

Scientific Title

Effect of continual intake of Satsuma mandarin on skin carotenoid level in human.

Scientific Title:Acronym

Effect of Satsuma mandarin on skin carotenoid level.

Region

Japan


Condition

Condition

none

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate changes of skin carotenoid level by intake of Satsuma mandarin.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Skin carotenoid levels during the intake period and the post-intake period.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Subjects can't eat Satsuma mandarin during the intake period (4 weeks) and the post-intake period (4 weeks).

Interventions/Control_2

Subjects eat one Satsuma mandarin every day during the intake period (4 weeks) and can't eat any Satsuma mandarin during post-intake the period (4 weeks).

Interventions/Control_3

Subjects eat three Satsuma mandarins every day during the intake period (4 weeks) and can't eat any Satsuma mandarin during the post-intake period (4 weeks).

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy employee of KAGOME Co. Ltd. who agreed to participate in the examination.

Key exclusion criteria

1.Skin carotenoid level is 8.0 or higher.
2.Food allergy to the test food.
3.Fasting blood glucose is 100 mg / dL or more, or those who have had diagnosis of diabetes in the past.
4.Planning to become pregnant or lactating during the examination period.
5.Participate in other human tests involving intake of foods rich in carotenoid at the start of this study.
6.Who judged as inappropriate by the responsible investigator.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Suganuma

Organization

KAGOME Co. Ltd.

Division name

Nature and wellness research department, Innovation division

Zip code


Address

17 Nishitomiyama, Nasushiobara, Tochigi

TEL

0287-36-2935

Email

Hiroyuki_Suganuma@kagome.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroki Hayashi

Organization

KAGOME Co. Ltd.

Division name

Nature and wellness research department, Innovation division

Zip code


Address

17 Nishitomiyama, Nasushiobara, Tochigi

TEL

0287-36-2935

Homepage URL


Email

Hiroki_Hayashi@kagome.co.jp


Sponsor or person

Institute

KAGOME Co. Ltd.

Institute

Department

Personal name



Funding Source

Organization

KAGOME Co. Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 10 Day

Date of IRB

2018 Year 10 Month 17 Day

Anticipated trial start date

2018 Year 10 Month 04 Day

Last follow-up date

2018 Year 12 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2019 Year 08 Month 06 Day


Other

Other related information



Management information

Registered date

2018 Year 10 Month 05 Day

Last modified on

2021 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039211


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name